Home / Brands / Fusion IV Pharmaceuticals, Inc.
Fusion IV Pharmaceuticals, Inc. Recalls
64 recalls on record · August 9, 2017 to March 11, 2020 · Drugs
Recalls by year
17
20
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
March 11, 2020DrugsFDA
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 60 mcg/30 mg/2 mg/0.15mg/ml, For
Hazard: Lack of Assurance of Sterility
March 11, 2020DrugsFDA
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 40 mcg/25 mg/0.5mg/0.01mg/ml, For
Hazard: Lack of Assurance of Sterility
March 11, 2020DrugsFDA
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 18 mcg/1.8mg/0.2mg/0.02mg/mL, For
Hazard: Lack of Assurance of Sterility
August 9, 2017DrugsFDA
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Testosterone Cypionate + Progesterone, 200 mg/ 2.5 mg/mL ,10 mL amber glass vials, Rx Only, Compounded by AXIA Pharmace
Hazard: CGMP Deviations